Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Stur

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Ophthalmology|November 4, 2004
Verteporfin in Photodynamic Therapy: report no. 5Francesco Bandello, Kevin Blinder, Neil M Bressler, et al.
Ophthalmology|September 13, 2005
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization studyYair Alster, Neil M Bressler, Susan B Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 6, 2003
Improvement after verteporfin therapyRajiv Anand, Neil M Bressler, Susan B Bressler, et al.
American Journal of Ophthalmology|September 12, 2003
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1Keven J Blinder, Shannon Bradley, Neil M Bressler, et al.
American Journal of Ophthalmology|April 3, 2004
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3Jennifer J Arnold, Kevin J Blinder, Neil M Bressler, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Ophthalmology|November 4, 2004
Verteporfin in Photodynamic Therapy: report no. 5Francesco Bandello, Kevin Blinder, Neil M Bressler, et al.
Ophthalmology|September 13, 2005
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization studyYair Alster, Neil M Bressler, Susan B Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 6, 2003
Improvement after verteporfin therapyRajiv Anand, Neil M Bressler, Susan B Bressler, et al.
American Journal of Ophthalmology|September 12, 2003
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1Keven J Blinder, Shannon Bradley, Neil M Bressler, et al.
American Journal of Ophthalmology|April 3, 2004
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3Jennifer J Arnold, Kevin J Blinder, Neil M Bressler, et al.
Pageof 5